The loss of E-cad expression has been considered a hallmark of cancer progression and metastasis [12, 13] via loss of heterozygosity of the chromosomal region 16q22.1 containing the CDH1 locus, nonsense mutations [14], or promoter methylation [15]. This evidence concerns the gene CDH1 and cancer.